← Eichor
Study identifier: NCT07507370 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

CARED : A Novel Rapid Treatment Paradigm for Depression

Condition: Major Depressive Disorder  ·  Sponsor: University of North Carolina, Chapel Hill

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The purpose of this study is to primarily assess the feasibility and secondarily assess the efficacy of a single session intervention (SSI) that combines non-invasive brain stimulation and psychotherapy for Major Depressive Disorder (MDD). investigators will recruit 30 people with MDD, with at least mild to moderate symptoms, who are resistant to typical treatments for Major Depressive Disorder. In this trial, participants will receive psychotherapy, Intermittent Theta Burst Stimulation Transcranial Magnetic Stimulation (iTBS), and either active or sham (placebo) Transcranial Alternating Current Stimulation (tACS).

This description comes directly from the study's public registry record.

Talk to the study team

Flavio Frohlich, PhD  ·  919-966-9929  ·  flavio_frohlich@med.unc.edu

Haileigh Taylor, BA  ·  919-966-9929  ·  hjtay@unc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Carolina Center for NeurostimulationChapel Hill, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07507370